1. Fales CL1, Barch DM, Rundle MM, Mintun MA, Snyder AZ, Cohen JD, Mathews J, Sheline YI. Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biological Psychiatry. 2008;63(4): 377- 48 . [Pubmed:17719567]
2. Pelton GH1, Soleimani L, Roose SP, Tabert MH, Devanand DP.Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study. Alzheimer disease and associated disorders. 2016;30(1):67-9. [Pubmed: 26398910]
3. Tabert MH1, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, AlbersMW, SternY.A 10-item smell identification scale related to risk for Alzheimer's disease. Annals of Neurology. 2005;58(1):155-60. [Pubmed: 15984022]
4. Fornaro M, Escelsior A, Rocchi G, Conio B, Magioncalda P, Marozzi V, Presta A, Sterlini B, Contini P, Amore M, Fornaro P, Martino M.BDNF plasma levels variations in major depressed patients receiving duloxetine. neurological sciences. 2015;36(5):729-34. [Pubmed: 25501804]
5. Jain V, Baitharu I, Prasad D, Ilavazhagan G. Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation. PLoS One. 2013 May 21;8(5):e62235. [Pubmed: 23704876]